Baxter International (NYSE:BAX) has posted revenues of $2.97 billion for the latest quarter, marking an 8% year-on-year increase and surpassing analysts' expectations by 5.7%. However, the company is dealing with a substantial net loss of $1.128 billion, driven in part by $485 million in goodwill impairments. Following the earnings report, Baxter's stock has fallen 7.8%, raising concerns about its future as it forecasts flat to 1% sales growth for 2026 and struggles with a decline in earnings per share.